Back to All News

Diplomat Pharmacy, Inc. (DPLO) - Initiation of Research Coverage

February 9, 2018

Lake Street Capital Markets Analyst Brooks O’Neil initiated coverage of Diplomat Pharmacy, Inc. (DPLO), with a BUY rating and price target of $35.00 (DPLO $23.86). Diplomat is the largest independent provider of specialty pharmacy services in the U.S. and the Company delivers unique solutions for patients, payors, providers, and manufacturers.

Contact Us


US Mail
920 Second Avenue South
Suite 700
Minneapolis, MN 55402

Email Us

Find Us